Ignite Creation Date:
2025-12-24 @ 11:36 PM
Ignite Modification Date:
2026-04-06 @ 5:52 PM
Study NCT ID:
NCT00089856
Status:
TERMINATED
Last Update Posted:
2008-11-05
First Post:
2004-08-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
Sponsor:
Cell Genesys
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
G-0029
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Cell Genesys, Inc
Old Organization:
Cell Genesys, Inc.